Dialysis Equipment Market Size to Reach USD 36.29 Bn by 2034

Vantage Market Research releases its latest comprehensive report on the ‘Dialysis Equipment Market’ with a forecast period of 2025-2034. In 2023, the global dialysis equipment market size was USD 19.70 billion, and is calculated at USD 20.94 billionin 2024. The market is calculated to reach USD 36.29 billion in 2034, and register a revenue CAGR of 6.3% over the forecast period (2025-2034).

Market Overview:

Global dialysis equipment sales has increased significantly in parallel with rising prevalence of chronic kidney disease (CKD) and End-Stage Renal Disease (ESRD). Demand for hemodialysis and peritoneal dialysis systems and machines continue to register steady demand, with in-center hemodialysis and Home Hemodialysis (HHD) therapy ranking high in demand. Demand for home-based is expected to continue to incline over the forecast period due to ease of use, automated and smart operations and features, and overall convenience and autonomy in treatments. 

Technological advancements and innovations in equipment and systems has also been resulting in rising appeal of new equipment across healthcare organizations. This includes wearable devices and portable dialysis equipment and machines, and automated systems that reduce the need for clinical supervision and emergence of biocompatible dialysis membranes that enhance patient treatment and comfort. Rising awareness regarding the benefits of early diagnosis and use of dialysis and treatment to slow down, manage, and delay progression of CKD is also contributing to incline in patient pool seeking treatment and opting for various devices and machines in the dialysis equipment market. 

Rapidly aging population globally is also a key factor driving demand for renal care and dialysis treatments, and in turn supporting revenue growth of the dialysis equipment market. Other factors are supportive government initiatives and reimbursement policies related to treatment and use of dialysis equipment. Governments and private organizations are engaging in initiatives to enable easier access for patients to dialysis treatments, especially in developing economies with high prevalence of kidney diseases. Also, initiatives supporting and encouraging early detection, diagnosis, and treatment of various chronic diseases and health conditions are also serving to drive expansion of healthcare infrastructure and modernization of facilities and offerings, and also driving growth of the dialysis equipment market.

However, cost and affordability factors can impact decision to purchase or upgrade existing equipment in healthcare facilities and hospitals. Dialysis can also be costly for some patients, especially in developing economies, and the long-term need for treatment can further add to the burden. In addition, innovation is crucial and R&D in dialysis technology, but can be costly and time-consuming. Developing new, more efficient machines with enhanced safety features requires substantial investment, and regulatory approval processes can further delay product launches. These challenges may slow down the pace of technological advancements, and can have a negative impact 

Moreover, availability of alternative treatments such as kidney transplant and regenerative medicine can have impact on market growth. Artificial kidneys and advancements in stem cell therapy are also potential factors expected to have a negative impact on growth of the dialysis equipment market in future.

Some Key Takeaways:

• The competitive landscape in the global dialysis equipment market is characterized by a mix of established players and emerging companies focused on innovation and technological advancements to offer more efficient and cost-effective equipment and systems.
• North America leads in terms of revenue share, and the trend is expected to continue over the forecast period, with the US accounting for majority revenue share.
• In Europe, Germany and the UK lead in terms of revenue share owing to robust healthcare systems and rising prevalence of kidney diseases, aging population, and increased focus on kidney health. 
• Rapid Asia Pacific dialysis equipment market revenue growth is driven by high contribution from Japan, India, and China.
• The hemodialysis equipment segment is expected to account for relatively larger revenue share compared to the peritoneal dialysis equipment segment over the forecast period. 
• Among the modality segments in the global dialysis equipment market, the in-center dialysis segment is expected to account for largest revenue share over the forecast period.
• The end-stage renal disease (ESRD) management segment is expected to account for largest revenue share among the application segments in the global dialysis equipment market over the forecast period.
• Among the end-user segments in the global dialysis equipment market, the dialysis centers segment is expected to account for largest revenue share over the forecast period. 

Company List:

• Fresenius Medical Care AG & Co. KGaA
• DaVita Inc.
• Baxter International Inc.
• B. Braun Melsungen AG
• Asahi Kasei Corporation
• Medtronic plc
• Nikkiso Co., Ltd.
• NIPRO Corporation
• JMS Co., Ltd.
• Toray Industries, Inc.
• Becton, Dickinson and Company (BD)
• Dialife
• Ecolab
• Cantel Medical Corp
• Rockwell Medical Inc.

Recent Developments:

• September 4, 2024: Fresenius Medical Care (FME), which is a global leader in kidney care, announced it achieved a growth milestone of over 14,000 US-based patients using its NxStage systems to perform Home Hemodialysis (HHD) therapy through both Fresenius Kidney Care clinics and other providers. In parallel, FME has also launched the newest version of its home dialysis machine, the NxStage Versi HD with GuideMe Software, featuring enhancements designed to simplify treatment, increase ease of learning, and improve user experience. The company has recorded an 18% increase in number of HDD patients starting treatment with NxStage in the US between January and April 2024 compared to same period in 2023. In April 2022, the company announced securing US Food and Drug Administration (FDA) 510(k) clearance for its Versi PD Cycler System1, which is a portable automated peritoneal dialysis cycler.
• May 8, 2024: Outset Medial Inc. announced receiving FDA 510(k) clearance of TabloCart with Prefiltration, which is an optional accessory for the Tablo Hemodialysis System. The TabloCart is a single solution device intended to streamline and make dialysis treatment more accessible, and comes in two versions, including one with added storage and one with water prefiltration capabilities. The announcement notice comes after Outset paused shipment of the device in August 2023 pending FDA clearance for marketing authorization, but has now resumed distribution in the US

Dialysis Equipment Market Segmentation:

By Product:

• Hemodialysis Equipment
• Peritoneal Equipment
• Continuous Renal Replacement Therapy (CRRT) Equipment
• Dialysis Accessories 

By Modality:

• In-Center Dialysis
• Home Dialysis

By Application:

• Acute Kidney Injury (AKI) Treatment
• End-Stage Renal Disease (ESRD) Management
• Chronic Kidney Disease (CKD) Treatment

By End-User:

• Hospitals
• Clinics
• Research Laboratories
• Home Healthcare Settings
• Dialysis Centers

Regional Segmentation: 

North America

• United States
• Canada
• Mexico

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Rest of Latin America 

Middle East & Africa

• Saudi Arabia
• South Africa
• United Arab Emirates
• Israel
• Rest of MEA